Conferences

Catalog

Abstracts

Calendar

5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Accreditation: 10.25 AMA PRA Category 1 Credit™ | 10.25 ABIM MOC II | 10.25 Nursing Contact Hours | 10.25 ACPE Pharmacy

Venue: InterContinental San Francisco, 888 Howard Street, San Francisco, CA, 94103, United States

Start Date: October 24End Date: October 25, 2025

Claim Now

Overview

Trusted by Thousands of Attendees
Across Our Events

79+

Email if you have questions

Our Speakers

Planning Committee

Mark Daniel Pegram, MD

Conference Chair

Stanford University

Faculty

Millie Das, MD

Session Chair

Stanford University/VA Palo Alto

Pamela Munster, MD

Session Chair

University of California San Francisco

Sylvia K. Plevritis, PhD

Session Chair

Stanford University School of Medicine

Henry T Greely, JD

Session Chair

Stanford Law School

Christopher Chen, MD

Session Chair

Stanford University

Mamta Parikh, MD

Session Chair

UC Davis Comprehensive Cancer Center

Marianne Dubard-Gault, MD

Session Chair

Swedish Health Services

Sachdev P Thomas, MD

Session Chair

Kaiser Permanente

James M. Ford, MD

Session Chair

Stanford University

Meera Ragavan, MD

Faculty

The Permanente Medical Group

Ora Karp Gordon, MD

Faculty

Providence Health

Stephen B. Gruber, MD, PhD, MPH

Faculty

City of Hope National Medical Center

Tian Yi Zhang, MD, PhD

Faculty

Stanford University

Alborz Alali, MD

Faculty

Woodland Memorial Hospital

Nathaniel James Myall, MD

Faculty

Stanford Cancer Center

Ibrahim Halil Sahin, MD

Faculty

Irene Wapnir, MD

Faculty

Stanford Healthcare

Ronan Hsieh, MD

Faculty

Swedish Cancer Institute

Shivaani Kummar, MD, FACP

Faculty

Oregon Health and Science University

Eric Rosen, MD

Faculty

Stanford University School of Medicine

Adil Daud, MD

Faculty

University of California San Francisco

Carlos Jose Suarez, MD

Faculty

Stanford University School of Medicine

Jason N Rosenbaum, MD

Faculty

Kaiser Permanente Northern California

Fangdi Sun, MD

Faculty

Stanford University

Chen Fu, MD

Faculty

Kaiser Permanente Vallejo Medical Center

Shruti Rajesh Patel, MD

Faculty

Stanford Health Care

Milana v Dolezal, MD

Faculty

Stanford School of Medicine

Haruka Itakura, MD, PhD

Faculty

Stanford University School of Medicine

Nicholas Mitsiades, MD

Faculty

UC Davis Comprehensive Cancer Center

Varun Monga, MD, MBBS

Faculty

University of California San Francisco

Arya Mariam Roy, MD

Faculty

Madhav Rao Seshadri, MD

Faculty

University of California, San Francisco

Surbhi Singhal, MD

Faculty

University of California Davis

Ana I. Velazquez Manana, MD

Faculty

University of California, San Francisco

Michael Snyder, PhD

Faculty

Stanford University School of Medicine

Rajat Thawani, MD

Faculty

Oregon Health and Science University

Uzma Waheed, MD

Faculty

Stanford University

Ilana Solomon, Other

Faculty

City of Hope National Medical Center

Nirosha Perera King, MD

Faculty

Agenda

Day 1: Friday, October 24th, 2025

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast & Exhibits

10:00 AM - 11:00 AMSession 1: Artificial Intelligence in Precision Oncology

Session Chair: Sylvia K. Plevritis, PhD

10:00 AM - 10:20 AM

Artificial Intelligence in Precision Oncology: Predicting Outcomes in Cancer – Haruka Itakura, MD, PhD

10:20 AM - 10:40 AM

Multi-modal AI for Cancer Biology and Clinical Decision Support – Sylvia K. Plevritis, PhD

10:40 AM - 11:00 AM

Panel Discussion – Haruka Itakura, MD, PhD; Sylvia K. Plevritis, PhD

11:00 AM - 12:00 PMSession 2: Oral Abstract Presentations

Session Chair: Marianne Dubard-Gault, MD

11:00 AM - 11:15 AM

Clinico-genomic Characterization of PALB2-Mutated Pancreatic Adenocarcinoma. – Jonathan Lee, MD

11:15 AM - 11:30 AM

Ph-like ALL Exhibits Unique Hematological Features with CD36 Overexpression: A Diagnostic and Prognostic Analysis of 1,021 Indian Patients. – Dikshat Gopal Gupta, PhD

11:30 AM - 11:45 AM

Race/ethnicity associated clinico-genomic, socioeconomic, and environmental predictors in metastatic non-small cell lung cancer (mNSCLC) treated with immunotherapy. – Nirosha Perera King, MD

11:45 AM - 12:00 PM

Utilization and Timing of First Tumor Next-generation Sequencing Testing (NGS) in Patients with Five Most Common Cancers in the USA. – Zeynep Irem Ozay, MD

12:00 PM - 01:00 PMLunch & Exhibits (Poster Presentation)

01:00 PM - 02:00 PMSession 3: Pathway-Based Targeted Therapies in Oncology

Session Chair: Pamela Munster, MD; Mark Daniel Pegram, MD

01:00 PM - 01:15 PM

RTK inhibitors in NSCLC – Nathaniel James Myall, MD

01:15 PM - 01:30 PM

PI3K Pathway – Pamela Munster, MD

01:30 PM - 01:45 PM

RAS/RAF in Melanoma – Adil Daud, MD

01:45 PM - 02:00 PM

Q & A/Discussion

02:00 PM - 03:20 PMSession 4: Molecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: Mark Daniel Pegram, MD

02:00 PM - 02:20 PM

ESR1 Mutation – Milana v Dolezal, MD

02:20 PM - 02:40 PM

MTAP Deletion – Shruti Rajesh Patel, MD

02:40 PM - 03:00 PM

KRAS G12C Mutation – Surbhi Singhal, MD

03:00 PM - 03:20 PM

EZH2 Mutation in Sarcoma – Varun Monga, MD, MBBS

03:20 PM - 03:30 PMBreak & Exhibits

03:30 PM - 04:00 PMSession 5: Liquid Biopsy and Non-Invasive Testing

Session Chair: Mamta Parikh, MD

03:30 PM - 04:00 PM

Panel Discussion – Nicholas Mitsiades, MD; Jason N Rosenbaum, MD; Ibrahim Halil Sahin, MD

04:00 PM - 04:45 PMSession 6: Roundtable Discussion: Ethical Challenges in Precision Oncology

Session Chair: Henry T Greely, JD

04:00 PM - 04:15 PM

Ethics in Precision Oncology – Henry T Greely, JD

04:15 PM - 04:45 PM

Panel Discussion – Sachdev P Thomas, MD; Meera Ragavan, MD; Alborz Alali, MD

04:45 PM - 05:30 PMSession 7: Personalized Cancer Vaccines in Immuno-Oncology

Session Chair: Pamela Munster, MD

04:45 PM - 05:05 PM

Development of Personalized Cancer Vaccines and Immunotherapy – Chen Fu, MD

05:05 PM - 05:30 PM

Panel Discussion – Adil Daud, MD; Chen Fu, MD

05:30 PM - 06:30 PMNetworking Reception Sponsored by Natera

Day 2: Saturday, October 25th, 2025

07:00 AM - 08:30 AMRegistration, Breakfast, and Exhibits

Acknowledgement of Commercial Support

This activity is supported with Independent Medical Education grants from Novartis, Merck, and Gilead.

About 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

Registration and pricing

Exhibitors and sponsorship

Agenda